Timely development of vaccines against SARS-CoV-2
Open Access
- 31 December 2019
- journal article
- editorial
- Published by Informa UK Limited in Emerging Microbes & Infections
- Vol. 9 (1), 542-544
- https://doi.org/10.1080/22221751.2020.1737580
Abstract
(2020). Timely development of vaccines against SARS-CoV-2. Emerging Microbes & Infections: Vol. 9, No. 1, pp. 542-544.Keywords
This publication has 13 references indexed in Scilit:
- Importation and Human-to-Human Transmission of a Novel Coronavirus in VietnamNew England Journal of Medicine, 2020
- An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategiesEmerging Microbes & Infections, 2020
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family clusterThe Lancet, 2020
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibodyEmerging Microbes & Infections, 2020
- Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routesEmerging Microbes & Infections, 2020
- HIV-1 did not contribute to the 2019-nCoV genomeEmerging Microbes & Infections, 2020
- RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreakEmerging Microbes & Infections, 2020
- EV71 vaccines: a milestone in the history of global vaccine developmentEmerging Microbes & Infections, 2014
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialNew England Journal of Medicine, 2012
- EV71: An emerging infectious disease vaccine target in the Far East?Vaccine, 2010